رجوع
مُدرج أيضًا باسم
MKGAF
OTC
نطاق اليوم
KWD 23.81
KWD 24.40
نطاق 52 أسبوعًا
KWD 23.76
KWD 31.00
حجم التداول
28,326
متوسط 50 يوم / 200 يوم
KWD 28.74
/
KWD 27.03
الإغلاق السابق
KWD 23.82
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 20.7 | 0.4 |
| P/B | 1.8 | 2.9 |
| ROE % | 8.6 | 3.7 |
| Net Margin % | 12.4 | 3.8 |
| Rev Growth 5Y % | 0.7 | 10.0 |
| D/E | 0.4 | 0.2 |
النقاط الرئيسية
Revenue grew 0.73% annually over 5 years — modest growth
Debt/Equity of 0.42 — conservative balance sheet
Generating 2.26B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.92%
Cash machine — converts 90.03% of earnings into free cash flow
Capital efficient — spends only 7.51% of revenue on capex
النمو
Revenue Growth (5Y)
0.73%
Revenue (1Y)-4.19%
Earnings (1Y)-9.79%
FCF Growth (3Y)13.17%
الجودة
Return on Equity
8.57%
ROIC7.22%
Net Margin12.36%
Op. Margin19.26%
الأمان
Debt / Equity
0.42
Current Ratio1.46
Interest Coverage15.52
التقييم
P/E Ratio
20.74
P/B Ratio1.82
EV/EBITDA15.67
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4.19% | Revenue Growth (3Y) | -1.74% |
| Earnings Growth (1Y) | -9.79% | Earnings Growth (3Y) | -5.82% |
| Revenue Growth (5Y) | 0.73% | Earnings Growth (5Y) | -4.84% |
| Profitability | |||
| Revenue (TTM) | 20.27B | Net Income (TTM) | 2.51B |
| ROE | 8.57% | ROA | 4.81% |
| Gross Margin | 56.35% | Operating Margin | 19.26% |
| Net Margin | 12.36% | Free Cash Flow (TTM) | 2.26B |
| ROIC | 7.22% | FCF Growth (3Y) | 13.17% |
| Safety | |||
| Debt / Equity | 0.42 | Current Ratio | 1.46 |
| Interest Coverage | 15.52 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 20.74 | P/B Ratio | 1.82 |
| P/S Ratio | 2.56 | PEG Ratio | -2.05 |
| EV/EBITDA | 15.67 | Dividend Yield | 0.02% |
| Market Cap | 51.96B | Enterprise Value | 61.18B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20.27B | 21.16B | 20.99B | 22.23B | 19.69B |
| Net Income | 2.51B | 2.78B | 2.82B | 3.33B | 3.06B |
| EPS (Diluted) | 1.15 | 1.28 | 1.30 | 1.53 | 1.41 |
| Gross Profit | 11.42B | 12.49B | 12.39B | 13.71B | 12.34B |
| Operating Income | 3.90B | 3.65B | 3.61B | 4.47B | 4.18B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 52.08B | 51.57B | 48.50B | 48.53B | 45.36B |
| Total Liabilities | 23.43B | 21.58B | 21.74B | 22.52B | 23.95B |
| Shareholders' Equity | 28.58B | 29.91B | 26.68B | 25.93B | 21.34B |
| Total Debt | 11.96B | 10.27B | 9.86B | 10.40B | 10.77B |
| Cash & Equivalents | 2.74B | 2.15B | 1.98B | 1.40B | 1.51B |
| Current Assets | 13.22B | 13.45B | 12.39B | 12.20B | 10.98B |
| Current Liabilities | 9.04B | 11.29B | 8.70B | 9.51B | 10.43B |